Publication Profile
Drug Early Warning from Re-Testing Biological Samples: Maryland Hospital Study; Office of National Drug Control Policy. Washington, DC: Executive Office of the President.
Wish, E.D., Billing, A.S., Artigiani, E.E., Dezman, Z., Schwartz, B., and Pueschel, J. (2018).